Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Unveiling the Hard Anodization Regime of Aluminum: Insight into Nanopores Self-Organization and Growth Mechanism.

Vega V, García J, Montero-Moreno JM, Hernando B, Bachmann J, Prida VM, Nielsch K.

ACS Appl Mater Interfaces. 2015 Dec 30;7(51):28682-92. doi: 10.1021/acsami.5b10712. Epub 2015 Dec 18.

PMID:
26646814
2.

Morphological, Chemical Surface, and Diffusive Transport Characterizations of a Nanoporous Alumina Membrane.

Vázquez MI, Romero V, Vega V, García J, Prida VM, Hernando B, Benavente J.

Nanomaterials (Basel). 2015 Dec 5;5(4):2192-2202. doi: 10.3390/nano5042192.

3.

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study.

Castelló A, Martín M, Ruiz A, Casas AM, Baena-Cañada JM, Lope V, Antolín S, Sánchez P, Ramos M, Antón A, Muñoz M, Bermejo B, De Juan-Ferré A, Jara C, Chacón JI, Jimeno MA, Rosado P, Díaz E, Guillem V, Lluch A, Carrasco E, Pérez-Gómez B, Vioque J, Pollán M; EpiGEICAM Researchers.

PLoS One. 2015 May 15;10(5):e0126096. doi: 10.1371/journal.pone.0126096. eCollection 2015.

4.

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.

Martín M, Martínez N, Ramos M, Calvo L, Lluch A, Zamora P, Muñoz M, Carrasco E, Caballero R, García-Sáenz JÁ, Guerra E, Caronia D, Casado A, Ruíz-Borrego M, Hernando B, Chacón JI, De la Torre-Montero JC, Jimeno MÁ, Heras L, Alonso R, De la Haba J, Pita G, Constenla M, González-Neira A.

Oncologist. 2015 Feb;20(2):111-2. doi: 10.1634/theoncologist.2014-0379. Epub 2015 Jan 19.

5.

Effect of Porosity and Concentration Polarization on Electrolyte Diffusive Transport Parameters through Ceramic Membranes with Similar Nanopore Size.

Romero V, Vega V, García J, Prida VM, Hernando B, Benavente J.

Nanomaterials (Basel). 2014 Aug 6;4(3):700-711. doi: 10.3390/nano4030700.

6.

Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.

Martín M, Ruiz A, Ruiz Borrego M, Barnadas A, González S, Calvo L, Margelí Vila M, Antón A, Rodríguez-Lescure A, Seguí-Palmer MA, Muñoz-Mateu M, Dorca Ribugent J, López-Vega JM, Jara C, Espinosa E, Mendiola Fernández C, Andrés R, Ribelles N, Plazaola A, Sánchez-Rovira P, Salvador Bofill J, Crespo C, Carabantes FJ, Servitja S, Chacón JI, Rodríguez CA, Hernando B, Álvarez I, Carrasco E, Lluch A.

J Clin Oncol. 2013 Jul 10;31(20):2593-9. doi: 10.1200/JCO.2012.46.9841. Epub 2013 Jun 3.

PMID:
23733779
7.

Changes in morphology and ionic transport induced by ALD SiO₂ coating of nanoporous alumina membranes.

Romero V, Vega V, García J, Zierold R, Nielsch K, Prida VM, Hernando B, Benavente J.

ACS Appl Mater Interfaces. 2013 May;5(9):3556-64. doi: 10.1021/am400300r. Epub 2013 Apr 25.

PMID:
23574388
8.

Structural and magnetization changes at high temperature in Co50Mn30In20 alloy.

Nazmunnahar M, González L, Ilyn M, del Val JJ, Suñol JJ, Hernando B, González J.

J Nanosci Nanotechnol. 2012 Sep;12(9):7442-5.

PMID:
23035491
9.

Exemestane for breast-cancer prevention in postmenopausal women.

Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H; NCIC CTG MAP.3 Study Investigators.

N Engl J Med. 2011 Jun 23;364(25):2381-91. doi: 10.1056/NEJMoa1103507. Epub 2011 Jun 4. Erratum in: N Engl J Med. 2011 Oct 6;365(14):1361.

Supplemental Content

Loading ...
Support Center